Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid

Toxicology in Vitro

Volumn 25, Issue 1, 2011, Pages 37-44

  Backorova M ^a   Backor M ^a   Mikes J ^a   Jendzelovsky R ^a   Fedorocko P ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Cancer cell; Cell cycle; Cytotoxicity; Lichen metabolites

Indexed keywords

ANTINEOPLASTIC AGENT; ATRANORIN; GYROPHORIC ACID; PHYSCION; UNCLASSIFIED DRUG; USNIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL NUCLEUS; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; DRUG SENSITIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LICHEN; MOLECULAR DYNAMICS; REACTION TIME; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOFURANS; BENZOIC ACIDS; CELL ADHESION; CELL LINE, TUMOR; CELL NUCLEUS SHAPE; CELL PROLIFERATION; CELL SURVIVAL; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; EMODIN; HUMANS; HYDROXYBENZOIC ACIDS; LICHENS; NEOPLASMS; OSMOLAR CONCENTRATION; S PHASE;

EID: 78650518842     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.09.004     Document Type: Article

References (27)

1. Ahmadjian V. The Lichen Symbiosis 1993, John Wiley and Sons, Inc., New York.
2. Asahina Y., Shibata S. Chemistry of Lichen Substances 1954, Japan Society for the Promotion of Science, Tokyo, 240pp.
3. Bézivin C., Tomasi S., Rouaud I., Delcros J.G., Boustie J. Cytotoxic activity of compounds from the lichen: Cladonia convoluta. Planta Med. 2004, 70:874-877.
4. Buďová J., Bačkor M., Bačkorová M., Židzik J. Usnic acid and copper toxicity in aposymbiotically grown lichen photobiont Trebouxia erici. Symbiosis 2006, 42:169-174.
5. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998, 282:1497-1501.
6. Burlando B., Ranzato E., Volante A., Appendino G., Pollastro F., Verotta L. Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds. Planta Med. 2009, 75:607-613.
7. Cardarelli M., Serino G., Campanella L., Ercole P., De Cicco Nardone F., Alesiani O., Rossiello F. Antimitotic effects of usnic acid on different biological systems. CMLS 1997, 53:667-672.
8. Dias D.A., Urban S. Phytochemical investigation of the Australian lichens Ramalina glaucescens and Xanthoria parietina. Nat. Prod. Commun. 2009, 4:959-964.
9. Fashelt D. Secondary biochemistry of lichens. Symbiosis 1994, 16:117-165.
10. Haraldsdóttir S., Gudlaugsdóttir E., Ingolfsdóttir K., Ogmundsdóttir H.M. Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro. Planta Med. 2004, 70:1098-1100.
11. Hauck M., Willenbruch K., Leuschner C. Lichen substances prevent lichens from nutritient deficiency. J. Chem. Ecol. 2009, 35:71-73.
12. Kawada K., Yonei T., Ueoka H., Kiura K., Tabata M., Takigawa N., Harada M., Tanimoto M. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay. Acta Med. Okayama 2002, 56:129-134.
13. Kumar S., Müller K. Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth. J. Nat. Prod. 1999, 62:821-823.
14. Kupchan S.M., Kopperman H.L. L - usnic acid: tumor inhibitor isolated from lichens. Experientia 1975, 31:625.
15. Latkowska E., Lechowski Z., Bialczyk J., Pilarski J. Photosynthesis and water relations in tomato plants cultivated long-term in media containing (+)-usnic acid. J. Chem. Ecol. 2006, 32:2053-2066.
16. Lawrey J.D. Biological role of lichen substances. Bryologist 1986, 89:111-122.
17. Mayer M., O' Neill M.A., Murray K.E., Santos-Magalhaes N.S., Carneiro-Leao A.M., Thompson A.M., Appleyard V.C.L. Usnic acid: a non-genotoxic compound with anti-cancer properties. Anti-Cancer Drugs 2005, 16:805-809.
18. Niyazi M., Niyazi I., Belka C. Counting colonies of clonogenic assays by using densitometric software. Radiation Oncology 2007, 2:4.
19. Pöykkö H., Hyvärinen M., Bačkor M. Removal of lichen secondary metabolites affects food choice and survival of lichenivorous moth larvae. Ecology 2005, 86:2623-2632.
20. Ren M.R., Hur J.S., Kim J.Y., Park K.W., Park S.C., Seong C.N., Jeong I.Y., Byun M.W., Lee M.K., Seo K.I. Anti-proliferative effects of Lethariella zahlbruckneri extracts in human HT-29 human colon cancer cells. Food Chem. Toxicol. 2009, 47:2157-2162.
21. Russo A., Piovano M., Lombardo L., Vanella L., Cardile V., Garbarino J. Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells. Anti-Cancer Drugs 2006, 17:1163-1169.
22. Russo A., Piovano M., Lombardo L., Garbarino J., Cardile V. Lichen metabolites prevent UV light and nitric oxide-mediated plasmid DNA damage and induce apoptosis in human melanoma cells. Life Sci. 2008, 83:468-474.
23. Solhaug K.A., Gauslaa Y. Parietin, a photoprotective secondary product of the lichen Xanthoria parietina. Oecologia 1996, 108:412-418.
24. Solhaug K.A., Lind M., Nybakken L., Gauslaa Y. Possible functional roles of cortical depsides and medullary depsidones in the foliose lichen Hypogymnia physodes. Flora 2009, 204:40-48.
25. Takai M., Uehara Y., Beisler J.A. Usnic acid derivatives as potential antineoplastic agents. J. Med. Chem. 1979, 22:1380-1384.
26. Yuan X., Xiao S., Taylor T.N. Lichen-like symbiosis 600 million years ago. Science 2005, 308:1017-1020.
27. Zeytinoglu H., Incesu Z., Tuylu B.A., Turk A.O., Barutca B. Determination of genotoxic, antigenotoxic and cytotoxic potential of the extract from lichen Cetraria aculeata (Schreb.) Fr. in vitro. Phytother. Res. 2008, 22:118-123.